Pharmacokinetics, distribution, and metabolism of the novel bioreductive alkylating indoloquinone EO9 in rodents
- 31 December 1992
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (4) , 713-716
- https://doi.org/10.1016/0360-3016(92)90509-g
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Gradient high-performance liquid chromatographic assay for the determination of the novel indoloquinone antitumour agent E09 in biological specimensJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- In vitro and in vivo evaluation of the indoloquinone EO-9 (NSC 382 459) against human small cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1989
- Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelinesEuropean Journal of Cancer and Clinical Oncology, 1987
- Mitomycin analogs I. Indoloquinones as (potential) bisalkylating agentsTetrahedron, 1987